Aptuit has increased its global capacity for active pharmaceutical ingredient (API) manufacture. The company has opened a 1,600-L/1,000-L reactor stream at its API facility in Oxford, UK and increased throughput at its 400-L reactors at its facilityin Verona, Italy.

The expansions will enable the company to increase throughput of integrated development programs, as well as deliver standalone API at 40-120 kg batch scale for early to mid-stage clinical trials.

Source: Aptuit